Author

Marissa Lally

Institutions: Hunter Medical Research Institute, University of Newcastle Australia

Observed institutions: Hunter Medical Research Institute, University of Newcastle Australia

OpenAlex ID: A5120334333

ID #898 Dordaviprone (ONC201) reverses T-cell sequestration in diffuse midline glioma models.

2026 · Olive Loughnan, Mika Persson, et al. · Neuro-Oncology Pediatrics

ID #998 Precision Targeting of PI3K/mTOR in Diffuse Midline Glioma: GCT007 as a Novel Brain-Penetrant PIK3CA Inhibitor

2026 · Evangeline Jackson, Ryan Duchatel, et al. · Neuro-Oncology Pediatrics

EXTH-89. Precision Targeting of PI3K/mTOR in Diffuse Midline Glioma: GCT007 as a Novel Brain-Penetrant PIK3CA Inhibitor

2025 · Evangeline Jackson, Ryan Duchatel, et al. · Neuro-Oncology

DMG-09. Targeting the PI3K/AKT/mTOR genetic dependency in combination with ONC201 for the treatment of diffuse midline glioma

2025 · Evangeline Jackson, Madisen Riley, et al. · Neuro-Oncology Pediatrics

Works count: 4

Citation count:

H-index:

I10-index: